Table 1.
Clinical variables | Marginal mandibulectomy n=43 % (n) | Marginal mandibulectomy with fasciocutaneous free flap n=9 % (n) | Segmental mandibulectomy with osseocutaneous free flap n=59 % (n) |
---|---|---|---|
Clinical T stage | |||
T1 | 54 (23) | 11 (1) | 11 (6) |
T2 | 37 (16) | 55 (5) | 20 (12) |
T3 | 0 (0) | 11 (1) | 5(3) |
T4 | 7 (3) | 23 (2) | 38 (22) |
NA | 2 (1) | 0 (0) | 26 (16) |
Clinical N stage | |||
N0 | 82 (35) | 66 (6) | 54 (31) |
N1 | 7 (3) | 23 (2) | 3 (2) |
N2 | 9 (4) | 11 (1) | 17 (10) |
NA | 2 (1) | 0(0) | 26 (16) |
Site | |||
Mandibular gingiva | 54 (23) | 23 (2) | 24 (15) |
Floor of mouth | 24 (11) | 55 (5) | 15 (9) |
Tongue | 9 (3) | 11 (1) | 5 (3) |
Retromolar trigone | 7 (3) | 0 (0) | 11 (6) |
Buccal mucosa | 4 (2) | 0 (0) | 1 (1) |
Mandible | 2 (1) | 0(0) | 44 (25) |
Tonsil | 0 (0) | 11 (1) | 0 (0) |
Pathology | |||
Squamous cell carcinoma | 96 (41) | 100 (9) | 74 (42) |
Dysplasia | 2 (1) | 0 (0) | 0 (0) |
Sarcoma | 0 (0) | 0 (0) | 14 (10) |
Mucoepidermoid carcinoma | 0(0) | 0 (0) | 1 (1) |
Benign lesions | 2 (1) | 0 (0) | 11 (6) |
Postoperative radiotherapy | |||
Yes | 23 (10) | 55 (5) | 63 (37) |
No | 77 (33) | 45 (4) | 37 (22) |
Postoperative chemotherapy | |||
Yes | 9 (4) | 23 (2) | 20 (12) |
No | 81 (39) | 77 (7) | 79 (47) |